A clinical trial of two conceptually different radical radiotherapy treatments in stage III carcinoma of the cervix.
Affiliation
Department of Radiotherapy, Christie Hospital and Holt Radium Institute, Manchester M20 9BX, UKIssue Date
1986-01
Metadata
Show full item recordAbstract
Two hundred and ninety-six consecutive patients under the age of 70 years and having Stage III carcinoma of the cervix were randomised to receive one of two radical radiotherapy techniques. The first was a small-field, wedged, inhomogeneous 3-week X-ray treatment, followed by two radical radium insertions delivering 80% of a radical intracavity dose. The second was a 4-week homogeneous, large-field X-ray technique, supplemented by a single intracavitary insertion giving 50% of a radical intracavitary dose. Mature 5-year survival rates for the two techniques were 38.6% and 40.3% respectively (p = 0.76). Corrected 5-year results were 44.5% and 45% (p = 0.8). The time to pelvic recurrence and the sites of pelvic recurrence were not significantly different. The rate of major morbidity was eight out of 148 in the first group and five out of 148 in the second. This large, prospective, randomised trial failed to identify any significant advantage to two conceptually different techniques which explored different volumes, fractionation and balance between X-ray therapy and intracavitary therapy. The overall results remain very satisfactory when compared with recently published European results.Citation
A clinical trial of two conceptually different radical radiotherapy treatments in stage III carcinoma of the cervix. 1986, 37 (1):23-7 Clin RadiolJournal
Clinical RadiologyDOI
10.1016/S0009-9260(86)80157-XPubMed ID
3514074Type
ArticleLanguage
enISSN
0009-9260EISSN
1365-229Xae974a485f413a2113503eed53cd6c53
10.1016/S0009-9260(86)80157-X